Cathie Wood's Ark Invest Goes Shopping For Moderna Stock — Sells DraftKings Shares Amid Quarterly Rise In Revenue, EPS Beat
Portfolio Pulse from Benzinga Neuro
Ark Invest, led by Cathie Wood, has made significant changes to its holdings, selling a large portion of DraftKings Inc (DKNG) shares and buying Moderna Inc (MRNA) stock. This comes despite DraftKings' positive earnings report and Moderna's current challenges with vaccine demand. Other trades include selling shares of NVIDIA Corp (NVDA), Ionis Pharmaceuticals Inc (IONS), and General Motors Co (GM).
November 03, 2023 | 2:27 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Ark Invest sold a significant portion of its DraftKings shares despite the company's positive earnings report.
The sale of a significant portion of DraftKings shares by Ark Invest could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Ark Invest trimmed its holdings in General Motors.
The trimming of General Motors shares by Ark Invest could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Ark Invest reduced its position in Ionis Pharmaceuticals.
The reduction in Ionis Pharmaceuticals shares by Ark Invest could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
NEGATIVE IMPACT
Ark Invest sold a portion of its NVIDIA shares.
The sale of NVIDIA shares by Ark Invest could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 80
POSITIVE IMPACT
Ark Invest purchased Moderna stock despite the company's current challenges with vaccine demand.
The purchase of Moderna stock by Ark Invest could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100